Abstract
We report a patient with advanced esophageal carcinoma associated with dermatomyositis who successfully maintained long-term good nutritional status by chemoradiation therapy and continuous enteral nutrition. A 64-year-old Japanese man was admitted to our hospital because of dysphagia and systemic edema. Because of debilitated status and malnutrition, intravenous corticosteroid infusion was first performed. Continuous enteral nutrition was performed through percutaneous endoscopic gastrostomy, and chemoradiation therapy was then performed. Although the endoscopic examination revealed complete regression of esophageal carcinoma, an esophagobronchial fistula was formed. The patient was periodically followed up by a multidisciplinary team for appropriate nutritional management; as a result, nutritional status was markedly improved and well maintained. A covered, selfexpandable metallic stent was placed in the esophagus to conceal the esophagobronchial fistula. This case highlights the importance of multidisciplinary therapeutic approach for maintaining good nutritional status and quality of life in patients with advanced esophageal carcinoma confounded by debilitating disorders.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Cheng S, Iannettoni M, Koshy M, Suntharalinam M, Urba S. Squamous cell carcinoma of the esophagus: treat with how many modalities? Semin Oncol 2009;36:493–497.
Kikuchi K, Seto Y, Matsubara T, Yamada K, Tamaki K. Amyopathic dermatomyositis associated with esophageal cancer. Int J Dermatol 2008;47:310–311.
Siloka SS, Ribeiro U, Kane JM III, Landreneau RJ, Lembersky B, Posner MC. Role of nutritional support during induction chemoradiation therapy in esophageal cancer. JPEN J Parenter Enteral Nutr 1998;22:18–21.
Nozoe T, Kimura Y, Ishida M, Saeki H, Korenaga D, Sugimachi K. Correlation of pre-operative nutritional condition with postoperative complications in surgical treatment for oesophageal carcinoma. Eur J Surg Oncol 2002;28:396–400.
Skipworth J, Foster J, Raptis D, Hughes F. The effect of preoperative weight loss and body mass index on postoperative outcome in patients with esophagogastric carcinoma. Dis Esophagus 2009;22:559–563.
Duclos A, Di Fiore F, Lecleire S, Michel P. Predictive and prognostic factors in patients with an esophageal carcinoma treated with chemoradiotherapy: the key role of nutritional parameters. Gastroenterol Clin Biol 2009;33:491–492.
Sakurai Y, Kanaya S, Komori Y, Uyama I. Is postoperative early enteral nutrition with regular or disease-specific enteral formula really beneficial in patients undergoing esophagectomy? Esophagus 2009;6:149–154.
Japanese Society for Esophageal Diseases. Guidelines for clinical and pathologic studies on carcinoma of the esophagus. 9th edn. Tokyo: Kanehara; 2001.
Callen JP. Cutaneous aspects of internal disease. Chicago: Yearbook Medical; 1981. p. 21–35.
Barnes BE, Mawr B. Dermatomyositis and malignancy. A review of the literature. Ann Intern Med 1976;84:68–76.
Callen JP, Hyla JF, Bole GG, Kay DR. The relationship of dermatomyositis and polymyositis to internal malignancy. Arch Dermatol 1980;116:295–298.
Callen JP. Dermatomyositis and malignancy. Clin Rheum Dis 1982;8:369–381.
Bohan A, Peter JB. Polymyositis and dermatomyositis (first two parts). N Engl J Med 1975;292:344–347.
Bohan A, Peter JB. Polymyositis and dermatomyositis (second two parts). N Engl J Med 1975;292:403–407.
de Marieux P, Verity MA, Clements PJ, Paulus HE. Esophageal abnormalities and dysphagia in polymyositis and dermatomyositis. Arthritis Rheum 1983;26:961–968.
Ohnmacht GA, Allen MS, Cassivi SD, Deschamps C, Nichols FC III, Pairolero PC. Percutaneous endoscopic gastrostomy risks rendering the gastric conduit unusable for esophagectomy. Dis Esophagus 2006;19:311–312.
Gonçalves F, Mozes M, Saraiva I, Ramos C. Gastrostomies in palliative care. Support Care Cancer 2006;14:1147–1151.
Lecleire S, Di Fiore F, Antonietti M, Ben Soussan E, Hellot MF, Grigioni S, et al. Undernutrition is predictive of early mortality after palliative self-expanding metal stent insertion in patients with inoperable or recurrent esophageal cancer. Gastrointest Endosc 2006;64:479–484.
Bethge N, Sommer A, Vakil N. Treatment of esophageal fistulas with a new polyurethane-covered, self-expanding mesh stent: a prospective study. Am J Gastroenterol 1995;90:2143–2146.
Song H-Y, Lung H-Y, Park S, Kim S-B, Lee D, Kang S-G, et al. Covered retrievable expandable nitinol stents in patients with benign esophageal strictures: initial experience. Radiology 2000;217:551–557.
Russell HM, de Hoyos AL, Blum MG. Successful management of recurrent Actinomyces esophagobronchial fistula with selfexpanding covered esophageal stent. J Thorac Cardiovasc Surg 2007;134:1086–1087.
Sarper A, Oz N, Cihangir C, Derircan A, Isin E. The efficacy of self-expanding metal stents for palliation of malignant esophageal strictures and fistulas. Eur J Cardiothorac Surg 2003;23:794–798.
Miwa K, Mitsoka M, Tayama K, Tomita N, Takamori S, Hayashi A, et al. Successful airway stenting using silicone prosthesis for esophagobronchial fistula. Chest 2002;122:1485–1487.
Sakurai Y, Ishiwatari A, Nishida T, Inaba K, Isogaki J, Uyama I, et al. Long-term clinical outcome in patients with percutaneous endoscopic gastrostomy. Jpn J Nutr Assess 2010;27:60–67.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sakurai, Y., Yoshimura, F., Furuta, S. et al. Multidisciplinary therapeutic approach for maintaining long-term nutritional status for patient with advanced esophageal carcinoma confounded by dermatomyositis. Esophagus 7, 157–164 (2010). https://doi.org/10.1007/s10388-010-0240-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10388-010-0240-x